Olaptesed pegol
Based on 1 publication(s) in Google Scholar
Olaptesed pegol (NOX-A12) is a L-oligoribonucleotide aptamer targeting CXCL12 based on a pegylated structure. Olaptesed pegol neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment. Olaptesed pegol can enhances the infiltration of human primary T cells and NK cells and inhibit tumor growth companied with anti-PD-1 antibody. Olaptesed pegol can be used for researches of colon cancer and lymphocytic leukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 95.94%
- CAS 番号: 1390628-22-4
- 分子量:54656 (Approximately)
-
保管条件:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
MedChemExpress(MCE)の使用を引用している文献 Olaptesed pegol
More
生物活性
CXCL12[1]
Olaptesed pegol (10-100 nM, overnight incubation) dose-dependently enhances the infiltration of human primary T cells (CD8+, CD4+) and NK cells in heterotypic tumor-stroma spheroids (PSN-1/MS-5, HT-29/MS-5, H1299/MS-5, U251MG/MS-5) containing CXCL12, slightly promotes B cell infiltration, has no effect on monocyte infiltration, and results in low levels of Treg cell infiltration[2].
Olaptesed pegol (10 nM, combined with anti-PD-1 antibody, overnight incubation) synergizes with anti-PD-1 antibody to enhance the activation of Jurkat PD-1/luc T cells in the MS-5/CHO-PD-L1 spheroid model[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice bearing CT-26 colorectal cancer syngeneic tumors[2]
-
Dosage:20 mg/kg
-
Administration:Subcutaneously injection, every other day, initiated on day 5
-
Result:Inhibited tumor growth with 5 out of 8 mice responding.
Olaptesed pegol alone had no significant inhibitory effect on tumor growth.
化学情報
-
CAS 番号 1390628-22-4
-
性状 Solid
-
分子量 54656 (Approximately)
-
Color White to off-white
-
SMILES
[Olaptesed pegol]
-
別名
NOX-A12
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Cancer Discov
2026 Jul 1;16(7):1382-1411. PMID: 41973996
純度とドキュメンテーション
-
データシート (270 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2242 KB)
参考文献
[1]. Steurer M, et al. Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia. Haematologica. 2019 Oct;104(10):2053-2060. [Content Brief]
[2]. Zboralski D, et al. Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade. Cancer Immunol Res. 2017 Nov;5(11):950-956. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)